Understanding the biology and prognosis of cerebral arteriovenous malformations

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate the biology of cerebral arteriovenous malformations (AVMs) and their associated prognosis. It focuses on understanding the mechanisms behind hemorrhagic strokes caused by AVMs, particularly the role of peri-nidal micro-vessels and the involvement of immune cells and platelets in maintaining microvascular integrity. Patients over 18 years old with cerebral AVMs will be monitored, and their consent will be obtained for participation. The study seeks to gather data that could enhance the understanding of AVMs and improve patient outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patient over 18 years old
* Patient with a cerebral AVM for which an intervention (endovascular treatment or surgery) or only clinical monitoring
* Express consent to participate in the study

And

* children
* Free informed and express consent of both holders of the minor patient's parental authority, or, by way of derogation and only if the other holder of parental authority cannot give his or her consent within a time limit compatible with the methodological requirements specific to the conduct of the research with regard to its purposes, of one of the two holders of parental authority

Exclusion Criteria:

* Patient benefiting from a legal protection measure
* Pregnant or breast feeding woman

Where it's running

• Fondation Ophtalmologique Rotschild
  Paris, France Recruiting

Study contacts

• Study coordinator: Amélie Yavchitz
• Email: ayavchitz@for.paris
• Phone: 01 48 63 64 54

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Registry for patients with Hereditary Hemorrhagic Telangiectasia

  This study is collecting information from people with Hereditary Hemorrhagic Telangiectasia to better understand the condition and help improve treatments in the future.

  Recruiting at 16 sites Cure HHT · Birmingham, Alabama and 15 other locations · NCT06259292

• Improving brain intervention planning using vascular mapping

  This study is testing new ways to plan brain surgeries for aneurysms and AVMs to make them safer and more effective by using advanced mapping and computer models.

  Recruiting University Hospital, Ghent · Ghent · NCT06588543

• Cognitive-sparing radiosurgery for brain metastases

  This study is testing a new way to use targeted radiation for patients with brain tumors to see if it can help protect their thinking skills while treating the cancer.

  Recruiting Phase 2 University of California, San Diego · San Diego, California · NCT04343157

• Evaluating outcomes in neurosurgery using standardized measures

  This study is trying to see how different factors affect the results of brain surgeries by collecting information from patients before and after their operations.

  Recruiting at 11 sites Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · Bergamo, BG and 26 other locations · NCT06724029

• Targeted therapies for patients with vascular malformations

  This study is testing new targeted treatments for patients with slow-flow and fast-flow vascular malformations to see if they work better than the usual therapies.

  Recruiting at 2 sites Phase 2 Murdoch Childrens Research Institute · Parkville, Victoria and 1 other locations · NCT05983159

• Genetic analysis of brain blood vessel malformations

  This study is trying to see how certain genetic changes might affect the development and outcomes of brain blood vessel malformations in patients who have them.

  Recruiting Fondation Ophtalmologique Adolphe de Rothschild · Paris · NCT04772963

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.